Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Beijing Gene Key Life Technology Co., Ltd

Clinical trials sponsored by Beijing Gene Key Life Technology Co., Ltd, explained in plain language.

Not yet recruiting 1

New drug combo tested for Tough-to-Treat liver cancer

Disease control Not yet recruiting

This study is testing if adding an experimental drug called GKL-006 to a standard liver cancer treatment (TACE) is more effective and safe. It will involve about 48 adults with advanced liver cancer that cannot be removed by surgery. The main goal is to see if the combination shr…

Phase: PHASE2 • Sponsor: Beijing Gene Key Life Technology Co., Ltd • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC